Bologna, Italy

Marinella Fantuz


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marinella Fantuz: Innovator in Heparin Derivatives

Introduction

Marinella Fantuz is a distinguished inventor based in Bologna, Italy. She has made significant contributions to the field of biochemistry, particularly in the development of heparin derivatives. Her innovative work focuses on enhancing the therapeutic properties of heparin while minimizing its adverse effects.

Latest Patents

Marinella Fantuz holds a patent for "Heparin derivatives and process for their preparation." This patent describes new heparin derivatives that possess antithrombotic activity while exhibiting reduced hemorrhagic and anticoagulant effects. The derivatives are obtained by treating heparins of various origins in a basic medium, optionally with alkali metal salts and a reducing agent. The resulting heparin derivatives display unique chimico-physical characteristics, including new signals in the 13C-NMR spectrum and an increase in specific rotatory power. These structural modifications enhance the biological properties of heparin, maintaining its antithrombotic activity while reducing the hemorrhagic effect in vivo and the anticoagulant activity in vitro. Marinella has 1 patent to her name.

Career Highlights

Marinella Fantuz has built a reputable career in the pharmaceutical industry, working with Alfa Wasserman S.p.a. Her research has focused on improving the safety and efficacy of anticoagulant therapies, making a significant impact on patient care.

Collaborations

Throughout her career, Marinella has collaborated with notable colleagues, including Silvano Piani and Gianfranco Tamagnone. These partnerships have contributed to the advancement of her research and the successful development of her patented innovations.

Conclusion

Marinella Fantuz is a pioneering inventor whose work on heparin derivatives has the potential to transform anticoagulant therapies. Her dedication to improving medical treatments showcases the importance of innovation in the pharmaceutical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…